Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study ; volume:20 ; number:1 ; day:23 ; month:4 ; year:2022 ; pages:1-10 ; date:12.2022
World journal of surgical oncology ; 20, Heft 1 (23.4.2022), 1-10, 12.2022
- Creator
-
Javed, Sahir
Benoist, Stéphane
Devos, Patrick
Truant, Stéphanie
Guimbaud, Rosine
Lièvre, Astrid
Sefrioui, David
Cohen, Romain
Artru, Pascal
Dupré, Aurélien
Bachet, Jean-Baptiste
Fouchardière, Christelle de la
Ploquin, Anne
Turpin, Anthony
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-022-02594-2
- URN
-
urn:nbn:de:101:1-2022070619001484579528
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Javed, Sahir
- Benoist, Stéphane
- Devos, Patrick
- Truant, Stéphanie
- Guimbaud, Rosine
- Lièvre, Astrid
- Sefrioui, David
- Cohen, Romain
- Artru, Pascal
- Dupré, Aurélien
- Bachet, Jean-Baptiste
- Fouchardière, Christelle de la
- Ploquin, Anne
- Turpin, Anthony
- SpringerLink (Online service)
Other Objects (12)
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report